Sign In
Buy VTRS
$17.56
-0.200 (-1.13%)
At Close: Jul 31, 2026
Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
09:00am, Saturday, 06'th Dec 2025
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions PITTSBURGH , Dec. 6, 2025 /PR
Mark Cuban Takes Aim at FDA Fees
02:08pm, Thursday, 04'th Dec 2025
Viatris (VTRS) and Teva Pharma (TEVA) could soon face fresh competition after billionaire entrepreneur Mark Cuban called on Washington to scrap a fee he says is
Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript
11:13am, Wednesday, 03'rd Dec 2025
Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript
Viatris Inc. (VTRS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
11:03am, Tuesday, 02'nd Dec 2025
Viatris Inc. (VTRS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Mapi Pharma is Seeking New Partnerships for Long-Acting Depot Drugs of Peptides for Self Administration
09:00am, Monday, 01'st Dec 2025
Management to Participate in 8th Annual Evercore Annual Healthcare Conference Management to Participate in 8th Annual Evercore Annual Healthcare Conference
Viatris to Participate in Upcoming Investor Conferences
08:00am, Monday, 24'th Nov 2025
PITTSBURGH , Nov. 24, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in Decembe
/PRNewswire/ - S príchodom Svetového týždňa povedomia o antimikrobiálnej rezistencii (AMR) uvádza Svetová zdravotnícka organizácia vo svojej Globálnej správe o
/PRNewswire/ -- Zu Beginn der Weltwoche zur Sensibilisierung für Antibiotikaresistenzen (AMR) zeigt der globale Bericht der Weltgesundheitsorganisation zur
/PRNewswire/ -- Wraz z rozpoczęciem Światowego Tygodnia Wiedzy o Antybiotykach (World AMR Awareness Week) raport Światowej Organizacji Zdrowia z 2025 r. na
Viatris Inc. (VTRS) Presents at Jefferies London Healthcare Conference 2025 Transcript
08:38am, Tuesday, 18'th Nov 2025
Viatris Inc. ( VTRS ) Jefferies London Healthcare Conference 2025 November 18, 2025 6:30 AM EST Company Participants Scott Smith - CEO & Director Theodora Mistras - Chief Financial Officer Philippe Ma
Viatris Recognized as One of the Fortune World's Best Workplaces™ in 2025
08:00am, Thursday, 13'th Nov 2025
PITTSBURGH , Nov. 13, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that it has been recognized as one of the Fortune World's Best Workplaces™ in 2025 . The list of 25 global
Viatris Inc. (VTRS) Presents at UBS Global Healthcare Conference 2025 Transcript
12:01pm, Tuesday, 11'th Nov 2025
Viatris Inc. ( VTRS ) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Theodora Mistras - Chief Financial Officer Conference Call Participants Ashwani Verma - U
Viatris Inc (VTRS) Q3 2025 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities
04:09pm, Thursday, 06'th Nov 2025
Total Revenues: $3.76 billion, down approximately 1% versus the prior year.Operational Revenue Growth: Approximately 1% excluding the indoor impact.Adjusted Gr
Viatris Inc. (VTRS) Q3 2025 Earnings Call Transcript
02:46pm, Thursday, 06'th Nov 2025
Viatris Inc. ( VTRS ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants William Szablewski Scott Smith - CEO & Director Philippe Martin - Chief R&D Officer Corinne Le Goff - Chie
Viatris Tops Q3 Earnings & Revenue Estimates, Ups '25 Guidance
11:25am, Thursday, 06'th Nov 2025
Viatris tops Q3 earnings and revenue estimates, lifts 2025 outlook, and expands its Japan presence with Aculys Pharma deal.
